Martin Fan

Stock Analyst at Wedbush

(4.78)
# 102
Out of 5,117 analysts
16
Total ratings
81.25%
Success rate
65.95%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Martin Fan

Zenas BioPharma
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $16.61
Upside: +170.92%
Vor Biopharma
Nov 25, 2025
Assumes: Neutral
Price Target: $9
Current: $10.58
Upside: -14.93%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $6.45
Upside: -68.99%
AnaptysBio
Nov 24, 2025
Reiterates: Outperform
Price Target: $50
Current: $43.20
Upside: +15.74%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5$6
Current: $4.06
Upside: +47.78%
Artiva Biotherapeutics
Oct 17, 2025
Maintains: Outperform
Price Target: $18$23
Current: $4.17
Upside: +451.56%
Cartesian Therapeutics
Jul 9, 2025
Initiates: Outperform
Price Target: $38
Current: $6.91
Upside: +449.93%
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $2.65
Upside: +201.89%
Oruka Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $40
Current: $26.88
Upside: +48.81%